Advanced soluble biomarker quantification using minimal sample volume, from the first global CRO to offer Olink Proximity Extension Assay (PEA) technology for clinical trials.
Quantify biomarkers with exceptional sensitivity and specificity from as little as 1 µL of sample. CellCarta offers the full spectrum of Olink PEA products, including Target 96 and Target 48 panels, Flex and Focus assays, Olink Explore, and Olink Reveal, across its global network of laboratories and is an Olink Certified Service Provider (CSP) in both Canada and China.
Using the Olink Signature Q100 instruments, we can support complex, low-abundance biomarker programs in immuno-oncology and beyond.
Quantify up to 92 carefully selected proteins across up to 88 samples simultaneously, using only 1µL of sample.
The Olink Target 96 and Target 48 panels let you focus on specific disease areas or biological processes, giving your team the targeted data needed to make confident therapeutic decisions.
Build the panel that fits your study. Flex lets you select up to 21 proteins from a library of approximately 200 validated biomarkers, while Focus deploys custom panels developed by Olink.
Both options enable absolute quantification and the flexibility to align assay design with your specific biological questions.
Explore over 1,000 proteins from as little as 4 µL of sample. With deep coverage across inflammation, immune responses, and oncology, Olink Reveal is built for early discovery programs where casting a wide net is essential to uncovering the right biomarkers.
Olink Explore enables large-scale multiplex discovery proteomics, with the capacity to investigate over 5400 analytes simultaneously. This platform is particularly well-suited for the early discovery phase, particularly for uncovering protein targets of interest.
Quantify up to 92 carefully selected proteins across up to 88 samples simultaneously, using only 1µL of sample.
The Olink Target 96 and Target 48 panels let you focus on specific disease areas or biological processes, giving your team the targeted data needed to make confident therapeutic decisions.
Build the panel that fits your study. Flex lets you select up to 21 proteins from a library of approximately 200 validated biomarkers, while Focus deploys custom panels developed by Olink.
Both options enable absolute quantification and the flexibility to align assay design with your specific biological questions.
Explore over 1,000 proteins from as little as 4 µL of sample. With deep coverage across inflammation, immune responses, and oncology, Olink Reveal is built for early discovery programs where casting a wide net is essential to uncovering the right biomarkers.
Olink Explore enables large-scale multiplex discovery proteomics, with the capacity to investigate over 5400 analytes simultaneously. This platform is particularly well-suited for the early discovery phase, particularly for uncovering protein targets of interest.
Olink’s PEA technology uses matched pairs of antibodies labeled with complementary DNA oligonucleotide tags. When both antibodies bind their target simultaneously, a unique DNA "barcode" is generated, allowing for two readout alternatives: NGS for large-scale protein biomarker discovery or qPCR for targeted biomarker discovery.
As an Olink Certified Service Provider in Canada and China, CellCarta delivers Olink workflows to the same standards of quality and consistency as Olink’s own facilities.
Hear from our team about what it means to be an Olink CSP, and how it can benefit your program.
CellCarta validated a 45-cytokine multiplex PEA panel in NSCLC plasma, delivering high sensitivity, precision, and differential immune profiling. This panel supports pharmacodynamic insights for oncology therapeutic development.
Olink Certified Service Provider delivering precise, multiplex biomarker data globally.
Full Olink Portfolio
Multi-Omic Integration
Global Execution
Low Sample Requirements
High-Plex Discovery
Combine Olink PEA with CellCarta’s broader suite of proteomic and analytical services.
Complement your proteomic data with precision biomarker detection across MSD, Ella, and ELISA platforms.
Extract the full value from your datasets with our in-house bioinformatics and biostatistics team.
Go broader with mass spectrometry and advanced unbiased discovery across your biological system.
CellCarta offers the full Olink assay suite: Target 96, Target 48, Flex, Focus, Reveal, and Explore. Target panels are ideal for focused, high-throughput studies quantifying up to 92 proteins from 1 µL of sample. Flex and Focus allow panel customization for defined biomarker hypotheses, while Reveal is designed for broad discovery programs profiling over 1,000 proteins from 4 µL of sample. Explore is well suited for discovery proteomics, investigating 5400+ target proteins from as little as 1 µL of sample. Our scientific team can help you select the right assay for your study design and sample availability.
CSP status is awarded to laboratories that demonstrate the ability to run Olink workflows to the same standards of quality and consistency as Olink’s own facilities. CellCarta holds CSP certification in both Canada and China, and undergoes annual concordance testing and re-certification to maintain that status. For sponsors, this means every Olink assay run at CellCarta comes with a built-in layer of quality assurance and regulatory confidence.
Olink Explore, Flex, Focus, Target 96, and Target 48 panels require as little as 1 µL of sample, while Olink Reveal requires as little as 4 µL, making Olink PEA technology well-suited for studies involving limited or rare clinical material. Compatible sample types include plasma, serum, cerebrospinal fluid, and more. Our team can advise on sample type and volume requirements during study design.
Yes. CellCarta can integrate Olink PEA data with outputs from its immune monitoring, histopathology, genomics, and proteomics platforms, all within a single partner relationship. Data can be brought together and analyzed using CellCarta’s proprietary CellEngine® software, enabling deeper biological insights.
